JPWO2022059779A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022059779A5 JPWO2022059779A5 JP2022550631A JP2022550631A JPWO2022059779A5 JP WO2022059779 A5 JPWO2022059779 A5 JP WO2022059779A5 JP 2022550631 A JP2022550631 A JP 2022550631A JP 2022550631 A JP2022550631 A JP 2022550631A JP WO2022059779 A5 JPWO2022059779 A5 JP WO2022059779A5
- Authority
- JP
- Japan
- Prior art keywords
- benzothiazol
- dihydrofuro
- optionally substituted
- imidazol
- imidazo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025106969A JP2025134941A (ja) | 2020-09-18 | 2025-06-25 | アミン誘導体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020157398 | 2020-09-18 | ||
| JP2020157398 | 2020-09-18 | ||
| JP2021122893 | 2021-07-28 | ||
| JP2021122893 | 2021-07-28 | ||
| PCT/JP2021/034327 WO2022059779A1 (ja) | 2020-09-18 | 2021-09-17 | アミン誘導体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025106969A Division JP2025134941A (ja) | 2020-09-18 | 2025-06-25 | アミン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022059779A1 JPWO2022059779A1 (https=) | 2022-03-24 |
| JPWO2022059779A5 true JPWO2022059779A5 (https=) | 2024-09-19 |
| JP7706775B2 JP7706775B2 (ja) | 2025-07-14 |
Family
ID=80776131
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550631A Active JP7706775B2 (ja) | 2020-09-18 | 2021-09-17 | アミン誘導体 |
| JP2025106969A Pending JP2025134941A (ja) | 2020-09-18 | 2025-06-25 | アミン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025106969A Pending JP2025134941A (ja) | 2020-09-18 | 2025-06-25 | アミン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230365589A1 (https=) |
| EP (1) | EP4215534A4 (https=) |
| JP (2) | JP7706775B2 (https=) |
| KR (1) | KR20230069162A (https=) |
| CN (1) | CN116209441A (https=) |
| AU (1) | AU2021343770A1 (https=) |
| BR (1) | BR112023003807A2 (https=) |
| CA (1) | CA3191617A1 (https=) |
| MX (1) | MX2023003245A (https=) |
| WO (1) | WO2022059779A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023008470A1 (ja) * | 2021-07-28 | 2023-02-02 | 住友ファーマ株式会社 | 縮環アミン誘導体 |
| WO2025170029A1 (ja) * | 2024-02-09 | 2025-08-14 | カルナバイオサイエンス株式会社 | ジヒドロキナゾリノン誘導体 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020084116A (ko) * | 2000-02-07 | 2002-11-04 | 애보트 게엠베하 운트 콤파니 카게 | 2-벤조티아졸릴 우레아 유도체 및 이의 단백질 키나제억제제로서의 용도 |
| EP1679308B1 (en) | 2003-10-15 | 2013-07-24 | Ube Industries, Ltd. | Novel indazole derivative |
| WO2008021338A2 (en) * | 2006-08-15 | 2008-02-21 | Wyeth | Tricyclic oxazolidone derivatives useful as pr modulators |
| JP2010163361A (ja) | 2007-04-27 | 2010-07-29 | Dainippon Sumitomo Pharma Co Ltd | キノリン誘導体 |
| KR20100010894A (ko) | 2008-07-23 | 2010-02-02 | 가부시키가이샤 키노파마 | Ｄｙｒｋ를 저해하는 화합물을 함유하는 의약 조성물 |
| US8470835B2 (en) | 2009-01-13 | 2013-06-25 | Glaxo Group Limited | Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase |
| TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
| CN102712601A (zh) * | 2009-11-12 | 2012-10-03 | 赛尔维他股份公司 | 化合物、其制备方法、药物组合物、化合物的用途、用于调节或调控丝氨酸/苏氨酸激酶的方法以及丝氨酸/苏氨酸激酶调节剂 |
| CA2816219C (en) | 2010-11-01 | 2019-10-29 | Portola Pharmaceuticals, Inc. | Nicotinamides as syk modulators |
| UY34200A (es) | 2011-07-21 | 2013-02-28 | Bayer Ip Gmbh | 3-(fluorovinil)pirazoles y su uso |
| US9446044B2 (en) | 2011-08-19 | 2016-09-20 | Diaxonhit | DYRK1 inhibitors and uses thereof |
| WO2013043002A1 (en) | 2011-09-23 | 2013-03-28 | Yuhan Corporation | Imide-containing benzothiazole derivative or its salt and pharmaceutical composition comprising the same |
| KR101916443B1 (ko) | 2012-07-26 | 2018-11-08 | 글락소 그룹 리미티드 | Pad4 억제제로서의 2-(아자인돌-2-일) 벤즈이미다졸 |
| RS63405B1 (sr) | 2013-10-25 | 2022-08-31 | Blueprint Medicines Corp | Inhibitori receptora faktora rasta fibroblasta |
| JP2015107945A (ja) | 2013-12-05 | 2015-06-11 | 国立大学法人京都大学 | 神経新生に関する化合物及び医薬組成物 |
| GB201401886D0 (en) * | 2014-02-04 | 2014-03-19 | Lytix Biopharma As | Neurodegenerative therapies |
| JP2017516850A (ja) | 2014-05-23 | 2017-06-22 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｊａｋ阻害剤である５−クロロ−２−ジフルオロメトキシフェニルピラゾロピリミジン化合物 |
| WO2016044641A2 (en) | 2014-09-17 | 2016-03-24 | Epizyme, Inc. | Carm1 inhibitors and uses thereof |
| GB201617339D0 (en) | 2016-10-12 | 2016-11-23 | Lytix Biopharma As | Therapeutic compounds |
| CN109206537B (zh) | 2018-10-10 | 2021-04-09 | 华熙生物科技股份有限公司 | 一种乙酰化透明质酸钠的制备方法及其应用 |
| US20230138851A1 (en) * | 2020-01-30 | 2023-05-04 | Carna Biosciences, Inc. | Novel alkyne derivatives |
-
2021
- 2021-09-17 EP EP21869461.0A patent/EP4215534A4/en active Pending
- 2021-09-17 WO PCT/JP2021/034327 patent/WO2022059779A1/ja not_active Ceased
- 2021-09-17 US US18/026,187 patent/US20230365589A1/en active Pending
- 2021-09-17 CA CA3191617A patent/CA3191617A1/en active Pending
- 2021-09-17 BR BR112023003807A patent/BR112023003807A2/pt not_active Application Discontinuation
- 2021-09-17 KR KR1020237012416A patent/KR20230069162A/ko active Pending
- 2021-09-17 MX MX2023003245A patent/MX2023003245A/es unknown
- 2021-09-17 AU AU2021343770A patent/AU2021343770A1/en active Pending
- 2021-09-17 CN CN202180063922.5A patent/CN116209441A/zh active Pending
- 2021-09-17 JP JP2022550631A patent/JP7706775B2/ja active Active
-
2025
- 2025-06-25 JP JP2025106969A patent/JP2025134941A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI841200B (zh) | 雜環類化合物、藥物組成物及其應用 | |
| JP2024532734A5 (https=) | ||
| AU2022265682A1 (en) | 2-aminobenzothiazole compounds and methods of use thereof | |
| TW202321242A (zh) | 雜環化合物及使用方法 | |
| EP4384160A1 (en) | Heterocyclic compounds and methods of use | |
| EP4479398A1 (en) | Quinazoline compounds and use thereof as inhibtors of mutant kras proteins | |
| JP2024517693A5 (https=) | ||
| AU2022264784A1 (en) | Heterocyclic compounds and methods of use | |
| AU2022325858A1 (en) | Heterocyclic compounds and methods of use | |
| ES2548532T3 (es) | Compuestos de pirrolopirimidina como inhibidores de CDK4/6 | |
| JP2025533831A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質のテザー型複素環式阻害剤及びその使用 | |
| JP2011500774A5 (https=) | ||
| JP7258843B2 (ja) | 二環式ケトン化合物及びその使用方法 | |
| JP2019508407A (ja) | 化合物、組成物及び方法 | |
| AU2012299227A1 (en) | Inhibitors of the renal outer medullary potassium channel | |
| JPWO2022059779A5 (https=) | ||
| JP2005519086A5 (https=) | ||
| JP2025134941A (ja) | アミン誘導体 | |
| JP2023138470A5 (https=) | ||
| US20250034167A1 (en) | Heterocyclic compounds and methods of use | |
| WO2026015785A1 (en) | Spirocyclic kras inhibitors for treating disease | |
| JP2023138470A (ja) | アミン誘導体を含有する医薬 | |
| RU2021105513A (ru) | Ингибиторы rmt5 |